Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-058464

Chief Operations Officer sold 7,500 shares at an average $18.49 ($138,688)

  • Chief Operations Officer acquired 3,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Newell Joe Chief Operations Officer 2020-11-13 Option exercise +3,500 $12.15 $42,525 125,703 D
Newell Joe Chief Operations Officer 2020-11-13 Sale −6,200 $18.36 $113,832 119,503 D
Newell Joe Chief Operations Officer 2020-11-13 Sale −1,300 $19.12 $24,856 118,203 D
Derivatives
Newell Joe Chief Operations Officer 2020-11-13 Option exercise · Employee Stock Option (Right to Buy) −2,833 50,167 D
Newell Joe Chief Operations Officer 2020-11-13 Option exercise · Employee Stock Option (Right to Buy) −667 16,333 D
Open-market sales · 7,500 sh · avg $18.49 · $138,688
Loading xslF345X03/doc4.xml…